STAGE IIA PANCREATIC CANCER AJCC V8
Clinical trials for STAGE IIA PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIA PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to starve tough pancreatic tumors
Disease control OngoingThis early-stage study is testing a new combination of two drugs, calaspargase pegol and cobimetinib, for people with advanced pancreatic cancer that has spread. The main goal is to find the safest and most effective dose. Researchers hope the two drugs will work together to cut …
Matched conditions: STAGE IIA PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New drug cocktail aims to boost immune system against pancreatic cancer before surgery
Disease control OngoingThis study is testing a four-drug combination given to patients before surgery for pancreatic cancer that can be removed. The treatment includes two standard chemotherapy drugs and two newer immunotherapy drugs designed to help the body's immune system fight the cancer. The main …
Matched conditions: STAGE IIA PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Sound waves supercharge cancer drugs in groundbreaking trial
Disease control OngoingThis study is testing a new method called sonoporation to see if it makes standard chemotherapy more effective for pancreatic cancer. Sonoporation uses ultrasound waves and tiny bubbles to help more of the chemotherapy drug get into the tumor. Researchers are comparing patients w…
Matched conditions: STAGE IIA PANCREATIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC